A Win For BiondVax Pharmaceuticals Ltd.
Tue, Jul 27, 2021 at 05:33 PM
BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ) rocketted at $3.44, representing a gain of 26.9%. From Mon, Jul 12, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Feb 16, 2021 at $5.88 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ)
BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.
Top 10 Gainers:
- Oragenics, Inc. (OGEN:NYSEMKT), 34.14%
- SGOCO Group, Ltd. (SGOC:NASDAQ), 29.56%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 26.94%
- TAL Education Group (TAL:NYSE), 25.23%
- MOGU Inc. (MOGU:NYSE), 23.3%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 20.83%
- IRSA Propiedades Comerciales S.A. (IRCP:NASDAQ), 20.37%
- JZXN (JZXN:NASDAQ), 19.16%
- Iterum Therapeutics plc (ITRM:NASDAQ), 17.53%